Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of mycophenolate mofetil in autoimmune diseases
NL-OMON53229Phase 4Recruiting
- Sponsor
- Zuyderland
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate mofetil in autoimmune disease, sponsored by Zuyderland. Primary endpoint: MPA AUC0-12. Started Oct 2023; status: recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
autoimmune disease
Beyond the preview
Go deeper on NL-OMON53229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53229.